These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29914292)

  • 21. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
    Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y
    BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
    Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
    Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
    Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF
    J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review.
    Jones SK; Wolf BJ; Froeliger B; Wallace K; Carpenter MJ; Alberg AJ
    Nicotine Tob Res; 2022 Mar; 24(5):633-642. PubMed ID: 34478556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.
    Ray R; Tyndale RF; Lerman C
    J Neurogenet; 2009; 23(3):252-61. PubMed ID: 19169923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort.
    Bousman CA; Rivard C; Haese JD; Ambrosone C; Hyland A
    Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):227-35. PubMed ID: 22223462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users.
    Zhu AZ; Renner CC; Hatsukami DK; Benowitz NL; Tyndale RF
    Addiction; 2013 Oct; 108(10):1818-28. PubMed ID: 23692359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.
    Chenoweth MJ; Sylvestre MP; Contreras G; Novalen M; O'Loughlin J; Tyndale RF
    Drug Alcohol Depend; 2016 Jan; 158():139-46. PubMed ID: 26644138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.
    Lee AM; Tyndale RF
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):7-14. PubMed ID: 16785264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
    Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM
    Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study.
    Pérez-Rubio G; López-Flores LA; Cupertino AP; Cartujano-Barrera F; Reynales-Shigematsu LM; Ramírez M; Ellerbeck EF; Rodríguez-Bolaños R; Falfan-Valencia R
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34205269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
    Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
    Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?
    Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
    Pharmacopsychiatry; 2014 Jan; 47(1):33-6. PubMed ID: 24127329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.
    Chen LS; Baker TB; Piper ME; Breslau N; Cannon DS; Doheny KF; Gogarten SM; Johnson EO; Saccone NL; Wang JC; Weiss RB; Goate AM; Bierut LJ
    Am J Psychiatry; 2012 Jul; 169(7):735-42. PubMed ID: 22648373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics and smoking behavior.
    Schnoll RA; Johnson TA; Lerman C
    Curr Psychiatry Rep; 2007 Oct; 9(5):349-57. PubMed ID: 17915073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An association study on the CHRNA5/A3/B4 gene cluster, smoking and psoriasis vulgaris.
    Zhu KJ; Liu Z; Liu H; Li SJ; Zhu CY; Li KS; Fan YM
    Arch Dermatol Res; 2014 Dec; 306(10):939-44. PubMed ID: 25297392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?
    David SP
    Addiction; 2014 Jan; 109(1):138-9. PubMed ID: 24438115
    [No Abstract]   [Full Text] [Related]  

  • 38. Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.
    Ramsey AT; Chen LS; Hartz SM; Saccone NL; Fisher SL; Proctor EK; Bierut LJ
    Transl Behav Med; 2018 Jan; 8(1):7-17. PubMed ID: 29385591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
    Lee AM; Jepson C; Hoffmann E; Epstein L; Hawk LW; Lerman C; Tyndale RF
    Biol Psychiatry; 2007 Sep; 62(6):635-41. PubMed ID: 17223085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.
    Zhu AZ; Zhou Q; Cox LS; David SP; Ahluwalia JS; Benowitz NL; Tyndale RF
    Clin Pharmacol Ther; 2014 Aug; 96(2):256-65. PubMed ID: 24733007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.